Article #1 of a 50-article series drawn from the Business Advisory Arena library. The mathematical identity behind every growth strategy ever conceived, and the reason a flat $1.5M implant practice probably has a $2M practice hiding inside it.
There is a $1.5M implant practice somewhere in your city right now. The doctor is competent. The team is loyal. The clinical outcomes are excellent. The Google reviews average 4.8 stars. And the practice has produced almost exactly $1.5M every year for the last four years.
The doctor’s instinct is the universal one: I need more new patients. So they call another marketing agency. They up the Google Ads budget. They redesign the website. They hire a content team. They post on Instagram. They book one more dental conference. And the next year, the practice produces $1.55M.
The doctor has done nothing wrong. They have simply chosen the most expensive, slowest, and most competitive of the only three options available to grow a business, and ignored the other two.
That practice, with no change in patient volume, no new advertising spend, and no associate hire, can mathematically become a $2M practice within twelve months. The math is not contested. It has been independently rediscovered by Peter Drucker, the direct-response copywriting tradition, Clayton Christensen, the SaaS Net Revenue Retention movement, Alex Hormozi’s Money Models, and the entire field of customer-equity marketing. The most cited articulation belongs to Jay Abraham, who has consulted with businesses across 465 industries and credits the framework with $75 billion in client growth across 10,000 companies.
The framework collapses every growth tactic ever conceived into a single algebraic identity.
Why does $1.5M in revenue come down to exactly three numbers?
Your revenue is not a list of activities. It is an identity with exactly three terms.
Every business’s revenue, in any time period, can be written exactly one way:
Revenue = (Number of Customers) × (Average Transaction Value) × (Frequency of Purchase)
This is not a heuristic. It is an identity. If you sell anything to anyone for money, your top-line revenue is precisely the product of those three numbers. A practice with 800 active patients × $1,875 average per visit × 1.0 visits per year produces exactly $1.5M. There is no fourth term. There is no growth tactic, cold ads, referrals, fee increases, upsells, recall systems, joint ventures, AI recognition, member plans, that does not operate on at least one of those three variables.
That is why Abraham, and everyone who has rediscovered this principle, collapses growth strategy into three buckets. Not because three is a memorable number. Because the math forces it.
The three levers:
- Increase the number of customers (acquisition)
- Increase the average transaction value (size of each sale)
- Increase the frequency of repurchase (how often each customer buys)
That is the entire surface area of business growth. Every initiative anyone has ever sold you collapses into one of those three.
Why does a new patient cost up to 25 times what keeping one costs?
Acquisition is the most-discussed lever and, by a wide margin, the most expensive.
This is the most-discussed lever in the marketing literature because it is the most visible. New patient counts show up in every monthly report. Marketing agencies pitch acquisition services. Industry publications write acquisition tactics. The entire AI recognition category, getting recommended by ChatGPT, Perplexity, Claude, and Gemini when prospective patients ask “who’s the best implant dentist near me?” lives here.
It is also, by a wide margin, the most expensive lever. Industry data consistently shows the cost of acquiring a new customer is 5 to 25 times the cost of retaining or expanding an existing one. For implant-specific patients, the documented Customer Acquisition Cost (CAC) sits at $300 to $600 per patient. Many practices spend $10,000 per month and produce $120,000 in implant revenue, a respectable 12:1 ROAS, but only after months of testing, ad-budget tuning, and landing-page iteration.
Lever 1 has three distinct sub-mechanisms most operators conflate:
- Net-new acquisition: cold ads, SEO, AI recognition, content marketing, paid social.
- Reactivation of dormant patients: patients who haven’t returned in 18+ months. The cheapest “new” customer you’ll ever get, because the acquisition cost was paid years ago.
- Reduced attrition: every patient who would have churned but didn’t is mathematically identical to a new acquisition, without the CAC.
Bain & Company’s foundational research, repeated across three decades and dozens of industries, found a consistent result: a 5% improvement in retention rate produces a 25–95% increase in profits, depending on industry. Retention is acquisition performed against your existing book.
Most implant practices treat all three sub-mechanisms as a single category called “marketing,” and then under-deploy two of them. A typical practice has 200 to 800 dormant patients sitting in its practice management system doing nothing. The doctor pays for Google Ads to acquire strangers while patients who already trust them, patients with missing teeth, failing dentition, and adult children with insurance, go uncontacted.
What are the 800 patients already in your system worth to you this year?
The patient base is the business. Everything else is overhead.
Most operators file the patient list mentally as a record of work already completed. Historical. Done. The advertising budget, by contrast, gets filed as growth, because that is where new things come from.
The customer-equity literature inverts that on evidence rather than sentiment. Rust, Lemon and Zeithaml’s conclusion in Driving Customer Equity is that the customer base is the business, and that the building, the chairs, the imaging, and the team are the overhead required to serve it.
There is a simple way to test whether you believe it. Imagine selling the practice next year. What is the buyer actually purchasing? Not the equipment, which they could buy new. Not the lease. They are buying the relationships and what those relationships will predictably be worth over the following decade. Every practice broker prices it exactly that way.
Which means the asset a buyer would pay the most for is, in most practices, the one receiving the least management attention.
The concrete form of that gap is the 200 to 800 dormant patients sitting in a typical practice management system, uncontacted past eighteen months. No owner would tolerate fifty thousand dollars of equipment sitting idle in a back room for a year and a half. The database version of the same waste is invisible, so it persists, while the practice pays $300 to $600 to acquire strangers who trust it less.
What is a single 5% fee increase actually worth on a $1.5M practice?
Average transaction value is the most under-used lever in implant dentistry.
The second lever raises how much each patient spends per visit or per case. The mechanisms are straightforward: raise prices, upsell to higher-tier offers, cross-sell complementary services, bundle, productize, present a fuller treatment plan.
For an implant specialist, Lever 2 hides in plain sight. The same patient consultation, presented as “single-tooth implant” ($3,000–$5,000), as “All-on-4 per arch” ($18,000–$30,000), or as “full-mouth reconstruction” ($40,000–$60,000+), produces wildly different revenue against the same chair time, the same staff, the same office overhead. The clinical decision is the patient’s. The presentation decision is the practice’s.
One widely repeated figure, published by the dental marketing firm Titan Web Agency, puts it starkly: fewer than 10% of patients notice a fee increase from $650 to $710. A 3-to-5% annual fee increase is invisible to patients and invisible to the marketplace. On a $1.5M practice, a single 5% fee increase adds $75,000 in pure margin, every year, compounding. A practice that has held fees flat for the last five years is leaving roughly $300,000 on the table that no marketing campaign can replace.
Yet most practice owners refuse to raise fees because of imagined patient backlash. They focus instead on lead generation. They spend $50,000 on a marketing campaign rather than $5,000 to upgrade their case presentation training, a Lever 2 investment that the practice-analytics vendors DentalIntel and Curve Dental report produces a 15–25% revenue lift per patient when systematized.
This is the part of the principle that should be uncomfortable: the doctor giving a patient back the ability to eat, speak, and be in a room with people without thinking about it, delivering a clinical outcome measured in decades rather than months, is pricing the work like a commodity service and avoiding fee conversations because they feel awkward.
Specific Lever 2 moves available to most implant practices today:
- Annual 3–5% fee increase, automatic and unemotional, like rent escalation.
- Premium materials tiers (zirconia vs. acrylic on All-on-4; Straumann or Nobel vs. economy implants), priced as upgrades not bundled defaults.
- Sedation upgrades: IV, oral, nitrous, priced as separate optional add-ons at $400 to $1,200 per case, with a 30 to 50% take rate when offered correctly.
- Bone grafting and sinus lifts, priced separately, $500 to $3,000 per graft.
- Cosmetic adjacencies: whitening, veneers, aesthetic design, offered to patients already mid-investment in full-arch work. The highest-conversion upsell moment in dentistry is a patient already in the chair making a major decision.
- Productized All-on-4 packages: “Full-Arch Complete: implants + sedation + premium teeth + warranty + first-year maintenance, $42,000 total.” Anchors price. Simplifies acceptance. Carries margin.
Each of these is operational. None requires a new lead source. All of them act on the patient who is already, today, sitting in a consultation chair.
What is a $40,000 implant patient worth after the case closes?
Frequency is where most implant practices have nothing at all.
The third lever increases how often the same customer transacts. Mechanisms include shortened repurchase cycles, recall systems, subscription or continuity programs, reactivation campaigns, follow-on procedures, maintenance contracts.
This is where the implant industry has its largest hidden asset, and its largest unrealized opportunity. Implant patients are typically treated as one-time transactions. The case completes. The patient exits. The practice goes back to hunting strangers on Google.
The clinical literature disagrees with this operating model. The American College of Prosthodontists’ clinical practice guidelines, published in JADA in 2016, advise that patients with implant restorations obtain a professional examination at least every six months, as a lifelong regimen, and more often for patients the dentist judges to be at higher risk because of age, their ability to keep up home care, or complications. An implant is not a closed case. It is a lifelong maintenance relationship the guideline has already written. On a book of 500 active implant patients, two maintenance visits per year at $250 per visit is $250,000 of recurring hygiene revenue annually, more once the higher-risk patients are seen more often. A practice that treats each case as a one-time transaction never sees it.
That is one Lever 3 move. There are more.
Every implant patient has a five-, ten-, and twenty-year clinical trajectory. The patient who placed a single-tooth implant in 2024 is often a candidate for the contralateral side in 2026, a full-arch case in 2028, and the opposing arch by 2030. Active case progression, where the doctor reviews each implant patient’s full mouth annually against a five-year horizon, turns one-time implant patients into multi-decade implant patients. Most practices have no such review.
Every implant patient also has a spouse, a parent, an adult child, an in-law. The patient who just paid $40,000 and is ecstatic with the outcome is the highest-converting referral source available anywhere in the practice’s marketing stack. A systematized referral request at the post-treatment euphoria moment, a documented procedure that runs every time, not “we ask sometimes”, captures the warm-lead conversion that most practices ignore entirely.
In-house dental membership plans ($35 to $50 per month: cleanings included, procedures discounted, priority booking) convert uninsured patients into recurring revenue at two to three times their otherwise-occasional contribution. Quarterly reactivation campaigns to lapsed implant patients recover 20 to 35% of lapsed patients, according to recall-software vendors, patients who already trust the doctor and may be facing peri-implantitis, failing implants, or case revisions.
These are all Lever 3 mechanisms. None of them requires a single new patient. All of them sit on top of customers already acquired and clinical relationships already trusted.
Why do two implant practices that started identical end up $500,000 apart in a single year?
The three numbers do not add. They multiply, which makes growth geometric rather than incremental.
Here is the math that makes the principle non-obvious and high-leverage:
- Baseline: 1.00 × 1.00 × 1.00 = 1.00×
- +10% on each lever: 1.10 × 1.10 × 1.10 = 1.331×, a 33.1% lift
- +25% on each lever: 1.25 × 1.25 × 1.25 = 1.953×, a 95.3% lift
- +50% on each lever: 1.50 × 1.50 × 1.50 = 3.375×, a 237.5% lift
(Customers × average transaction value × frequency.)
The three numbers do not add. They multiply. A 10% improvement on each does not produce a 30% revenue lift; it produces 33.1%. A 25% improvement on each nearly doubles revenue. A 50% improvement more than triples it.
This is the geometric growth insight that Abraham crystallized from the older streams. As he put it: “1,000 clients × $100 transaction × 2 transactions per year = $200,000. Increase those three numbers by 10% and your income expands by 33.1%. Increase them by 25% and your performance nearly doubles to $390,625.”
Now consider what this means for the $1.5M practice.
Baseline: 800 active patients × $1,875 average per year × 1.0 visits = $1.5M.
A modest 10% improvement on each lever:
- 800 patients → 880 (one referral system installed, a handful more reactivations per month)
- $1,875 AOV → $2,063 (one 5% fee increase, one productized package, slightly better treatment presentation)
- 1.0 visits/year → 1.1 (one lifelong implant maintenance recall, one quarterly reactivation campaign)
- New revenue: 880 × $2,063 × 1.1 = $1,996,684, a $497,000 lift, 33% growth, no new marketing spend.
An aggressive 25% improvement on each lever:
- 1,000 patients
- $2,344 AOV
- 1.25 visits/year
- New revenue: 1,000 × $2,344 × 1.25 = $2,930,000, nearly double, 95% growth.
This is the compounding effect. The doubling did not come from doubling marketing spend, doubling the patient base, or hiring associates. It came from operating all three levers simultaneously at moderate levels.
Which 2 of your 3 revenue numbers has your monthly report never shown you?
Working one lever is not a discipline failure. It is a structural one.
If the math is this clean, the question is obvious: why doesn’t every practice operate this way?
Five reasons, all observable in the field.
First, Lever 1 is the only visible lever. New patient counts show up in every monthly report. AOV trends and visit frequency typically do not; most dental practice management systems do not produce a usable monthly view of those numbers. Operators focus where attention is directed. No report flags “fees you haven’t raised in 18 months,” and nothing alerts you to “implant patients who never re-entered recall.”
Second, Lever 1 is the only lever someone is selling you. Marketing agencies sell new patient acquisition. SEO firms sell new patient acquisition. AI recognition firms, including ours at SytecAI, sell new patient acquisition. There is no agency selling “raise your fees by 4% next month and enroll every implant patient in lifelong maintenance recall.” Lever 1 has an industry. Levers 2 and 3 have only operational opportunity.
Third, pricing is culturally uncomfortable. Dentists, like most professionals, are trained in their craft, not their economics. Patients voice price complaints loudly. Patients who value the work and are happy to pay rarely volunteer it. The doctor absorbs the negative signal disproportionately, and the result is chronic under-pricing relative to value delivered.
Fourth, the existing customer base is invisible as an asset. Most operators view the patient list as a byproduct of operations. The customer-equity literature, particularly Rust, Lemon, and Zeithaml’s Driving Customer Equity, points to the opposite conclusion: the customer base IS the business. Everything else is overhead. Operators who internalize this stop spending $50,000 on marketing campaigns while leaving $5,000 of recall-system upgrades undone.
Fifth, and most subtly: the principle requires belief that the rules apply to your specific industry. Every doctor, in every market, has a story about why “implants don’t repurchase” or “my patients won’t pay more” or “we tried recall and it didn’t work.” The framework is mathematically universal; there is no industry where it fails. There are only industries where operators have not yet figured out the mechanism. When a doctor says “implants don’t repurchase,” they are missing maintenance, contralateral cases, full-arch progression, family referrals, and the entire seven-to-ten-year patient lifecycle.
This is what we call, inside the Business Advisory Arena, the Translation Gap: the distance between generic business advice and a specific decision in a specific practice. The Three Ways framework is universal. Translating it into “raise the All-on-4 package fee by $1,200 next Tuesday and install a quarterly reactivation campaign on the 412 patients lapsed past 18 months” is what produces the actual revenue.
Which comes first: the $75,000 fee increase or the 412 dormant patients?
The order the levers are installed in matters more than the levers themselves.
Counter to Abraham’s “do all three at once for geometric effect,” the honest reality is that a stuck practice cannot simultaneously install a referral system, raise fees, train treatment presenters, build a recall sequence, and add a membership plan. They fail at all of them.
After cross-referencing every source, Abraham, Hormozi, Brunson, Verne Harnish, the SaaS NRR research, the customer-equity literature, the most reliable order of operations is:
- Months 1–2: Fix Lever 2 quick wins. Fee schedule audit. Basic case presentation upgrade. Productize one premium tier. This is cheap, fast, and uses no new patients.
- Months 2–4: Install one Lever 3 system at a time. Lifelong implant maintenance recall. Quarterly reactivation campaign. Membership plan.
- Months 4–8: With Lever 2 and Lever 3 producing more revenue per patient, now invest in Lever 1 expansion. Higher patient value funds higher CAC. You can outbid the practice across town because each patient is worth more to you than it is to them.
- Months 8 onward: Operate all three simultaneously. Monthly scorecard reviewing (patients seen) × (average production per patient) × (visit frequency) as the central practice metric.
This order matters because most consultants and marketing agencies sell Lever 1 services first; it is the most visible and the most sellable. But Lever 1 alone is fragile, expensive, and defensible only if Levers 2 and 3 are working underneath it.
The doctors who win do not out-spend competitors on ads. They make each acquired patient worth more, then can afford the higher CAC. Dr. Alex Planes at Implants 4 All in Treasure Coast, Florida went from 6 to 8 full-arch cases per month to 40+ per month. His marketing agency’s own case study does not credit the ads alone. It credits the combination: implant-focused campaigns, a website rebuilt around implants, and ongoing training for his team on presenting and closing cases through The Closing Institute. The Lever 1 spend paid off because a presentation skill was installed underneath it. A multi-location dental group in the AnnexMed case study captured 27% more revenue from existing implant cases through pure Lever 2, better billing and documentation of multi-appointment cases, with no new patients, no new procedures, and no new marketing.
5 questions about your own practice. How many can you answer without checking?
The principle becomes operational only when you can see your own numbers.
The Three Ways framework becomes operational only when you can see your own numbers. Most practice owners cannot, off the top of their head, answer these five questions. The first one to make you pause is also the one with the most opportunity behind it.
1. When did you last raise your fees? By how much?
If more than 18 months, you have found a Lever 2 quick win. A 5% fee increase on a $1.5M practice is $75,000 of pure margin. Less than 10% of patients will notice.
2. What percentage of your patients return for a second appointment within 12 months?
If you cannot answer this without checking the practice management system, that is the answer. Lever 3 cannot be managed if it is not measured.
3. How many dormant patients sit in your PMS, patients who have not been in for 18 months or more?
Most practices have 200 to 800. Reactivation campaigns produce 20 to 35% re-engagement at a fraction of the cost of net-new acquisition. This is the cheapest new-patient channel you own.
4. Does every implant patient leave treatment enrolled in a lifelong maintenance recall?
The ACP guideline published in JADA calls for a professional examination at least every six months, for life, more often for higher-risk patients. A patient whose case closes without that enrollment is roughly $500 a year in uncaptured hygiene revenue at $250 a visit, and more for the higher-risk patients.
5. What is your case acceptance rate on full-arch cases versus single-tooth?
If you do not know, your treatment presentation is operating on guesswork. Industry data shows that systematized treatment presentation produces a 15 to 25% revenue lift per patient. The case presenter is the single highest-leverage hire or training investment in the practice, and the one most under-developed.
Score yourself honestly. Each question you cannot answer crisply is not a failure; it is a Lever you have not yet made visible. And every Lever you make visible becomes one you can move.
What does $497,000 of growth actually look like, month by month?
Twelve months of unremarkable operational decisions produce a $497,000 lift.
Return to the practice we opened with. The $1.5M flat-revenue practice with the 4.8-star reviews and the loyal team.
The doctor decides to stop adding marketing spend and starts working through the framework. In month one, they raise the All-on-4 package fee by $2,000. They productize a “Full-Arch Complete” tier. They train the treatment coordinator on a structured case presentation.
In month three, they install a quarterly reactivation campaign on 412 lapsed patients. They enroll every existing implant patient in lifelong maintenance recall: every six months, more often for the patients the doctor judges to be at higher risk. They create a documented referral request at every post-treatment review.
In month six, they add a $39 per month membership plan for uninsured patients.
In month nine, with the practice now producing 18% more revenue per existing patient than twelve months earlier, they double the Google Ads budget. The unit economics now justify it. Patients are worth more, so they can afford to acquire more.
In month twelve, the practice produces $1.97M.
The doctor did not work harder. They worked the math.
Why does every other growth question start here?
The Three Ways is the master frame every other business principle operates inside.
The Three Ways to Grow is the master frame within which every other business principle operates. That is why it is Principle #1 in the Business Advisory Arena library of 100.
Take a question a specialist might bring to any advisor: “My revenue is flat at $1.5M and I am thinking of acquiring another practice.” The right answer does not start with the acquisition. It starts with the three numbers: how many active patients, what the average per-patient revenue is, what the visit frequency is. It finds which of the three levers is the binding constraint. Only then does it reach for the principle that solves for that lever: Premium Positioning (#7) for Lever 2 pricing, Referral Engineering (#18) for Lever 1 acquisition, the LTV:CAC ratio (#2) for the unit economics underneath all three.
The Three Ways is the diagnostic frame. The other 99 principles are the tools that operate within it.
Before you buy the next acquisition, the next campaign, or the next associate, answer the five questions above.
The lever you have been ignoring is usually the cheapest one you own.
This article is #1 of a 50-article series translating the highest-leverage business principles ever proven to grow a service-based practice into the specific situation of a dental implant specialist. Each draws on a full principle dossier, for this one, 70+ sources, expanded sub-levers, additional case studies, and a complete cross-source synthesis, from the Business Advisory Arena library, currently in development.
Built by SytecAI. Headquarters of the Translation Gap.